Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells

In conclusion, these data reveal that diffractaic acid may be considered an effective therapeutic agent for breast cancer treatment.PMID:35569514 | DOI:10.1016/j.cbi.2022.109984
Source: Chemico-Biological Interactions - Category: Molecular Biology Authors: Source Type: research